US Patent 10392666 Non-invasive determination of methylome of tumor from plasma
Patent 10392666 was granted and assigned to The Chinese University of Hong Kong Chorus on August, 2019 by the United States Patent and Trademark Office.
All edits
Systems, methods, and apparatuses can determine and use methylation profiles of various tissues and samples. Examples are provided. A methylation profile can be deduced for fetal/tumor tissue based on a comparison of plasma methylation (or other sample with cell-free DNA) to a methylation profile of the mother/patient. A methylation profile can be determined for fetal/tumor tissue using tissue-specific alleles to identify DNA from the fetus/tumor when the sample has a mixture of DNA. A methylation profile can be used to determine copy number variations in genome of a fetus/tumor. Methylation markers for a fetus have been identified via various techniques. The methylation profile can be determined by determining a size parameter of a size distribution of DNA fragments, where reference values for the size parameter can be used to determine methylation levels. Additionally, a methylation level can be used to determine a level of cancer.
US Patent 10392666 Non-invasive determination of methylome of tumor from plasma
Find more entities like US Patent 10392666 Non-invasive determination of methylome of tumor from plasma
